World Cystic Fibrosis Day: The situation in Greece
On the occasion of World Cystic Fibrosis Day, the medical community in Greece is highlighting the importance of awareness regarding the disease. Cystic fibrosis is a serious hereditary condition that primarily affects the respiratory and digestive systems, creating difficulties in the daily lives of patients.
According to official data, it is estimated that there are approximately 500,000 carriers of the disease gene in Greece. Although carriers do not exhibit symptoms, it is important for them to be aware of their status, especially when planning to have children, as there is a possibility they may pass the disease on to their offspring.
Currently, more than 900 patients in Greece are receiving specialized treatment for cystic fibrosis. The progress of medical science in recent years has offered new, innovative therapies that significantly improve the quality of life for patients and increase their life expectancy.
Early diagnosis remains the most powerful weapon in combating the disease. Experts emphasize that prenatal screening and raising awareness among the general population are essential steps to limit the impact of cystic fibrosis on Greek society.
World Cystic Fibrosis Day serves as an opportunity to recognize the efforts of patients and their families. At the same time, it serves as a reminder of the need for continuous support for healthcare structures, ensuring that all patients have access to the necessary medical treatments and appropriate medical monitoring.